Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Periprocedural atorvastatin therapy in patients undergoing PCI
2009-010842-67Phase 4Completed
- Sponsor
- Fondazione Toscana Gabriele Monasterio
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of atorvastatin in coronary arteriosclerosis and type 2 diabetes mellitus (T2DM), sponsored by Fondazione Toscana Gabriele Monasterio. Primary endpoint: Change in serum sLOX-1 levels. Started Mar 2009; status: completed.
02
Drugs
atorvastatin
03
Conditions
coronary arteriosclerosistype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2009-010842-67.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010842-67.